CytomX Therapeutics (CTMX)
(Delayed Data from NSDQ)
$1.88 USD
+0.01 (0.53%)
Updated May 22, 2024 04:00 PM ET
After-Market: $1.83 -0.05 (-2.66%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth D Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-0.06 | -39.13% |
Earnings Summary
For their last quarter, CytomX Therapeutics (CTMX) reported earnings of $0.17 per share, beating the Zacks Consensus Estimate of $-0.06 per share. This reflects a positive earnings surprise of 383.33%. Look out for CTMX's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.06 per share, reflecting a year-over-year decrease of 200%.
Earnings History
Price & Consensus
Zacks News for CTMX
Vanda (VNDA) to Report Q1 Earnings: What's in the Cards?
CTMX: What are Zacks experts saying now?
Zacks Private Portfolio Services